Narayana Hrudayalaya Ltd (NH) — shareholding pattern, promoter holding, financials and share price

About Narayana Hrudayalaya Ltd (NH)

Narayana Hrudayalaya Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as NH and on the BSE under scrip code 539551. Its ISIN is INE410P01011.

Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. [1]

Narayana Hrudayalaya Limited is a multi‑speciality and super‑speciality healthcare operator founded by Dr. Devi Prasad Shetty, running a network of hospitals, clinics and management‑run facilities across India and international markets including Cayman Islands and the UK, offering tertiary care, robotic procedures, oncology and cardiac services alongside integrated care and an insurance business.

Recent quarters show meaningful margin expansion in the India portfolio driven by a multi‑year transformation: payor‑mix optimisation, higher‑realisation cases including robotic cardiac and bone marrow transplants, and technology infusion have driven 150–200 bps YoY margin improvement in the India business with management intent to sustain these gains where possible.

Listed peers in Hospital: Aster DM Healthcare Ltd, Global Health Ltd, Krishna Institute of Medical Sciences Ltd, Dr Agarwals Health Care Ltd, Rainbow Childrens Medicare Ltd, Park Medi World Ltd.

Valuation & Returns

10 Jul 2026

At ₹2,024.95 a share on 10 Jul 2026, Narayana Hrudayalaya Ltd (NH) was valued at a price-to-earnings ratio of 51.06x against an industry P/E of 61.73x and a price-to-book of 11.41x on a book value of ₹177.45 per share as of Mar 2025. Solomo computes return on equity of 22.35% and return on capital employed of 20.03% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
51.06x
Industry P/E
61.73x
P/B
11.41x
EPS (TTM)
₹39.66
Book value / share
₹177.45
ROE
22.35%
ROCE
20.03%
ROA
11.16%
Debt / equity
0.67x
Dividend yield
0.22%
EBITDA margin
20.97%
52-week range
₹1,564.25 – ₹2,094.3

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Narayana Hrudayalaya Ltd (NH) reported revenue of ₹7,896 crore, net profit of ₹806 crore and earnings per share of ₹39.42. That compares with revenue of ₹5,483 crore and net profit of ₹791 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹2,594 crore and net profit ₹224 crore (consolidated).

Consolidated annual results for Narayana Hrudayalaya Ltd (NH), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)3,7014,5254,8905,4837,896
Net profit (₹ cr)342607790791806
EPS (₹)16.7329.6738.6238.6639.42
Compound annual growth for Narayana Hrudayalaya Ltd (NH). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth10.43%9.90%14.18%12.12%
Profit growth25.29%44.79%47.78%0.13%
Stock price CAGR21%32%25%4%

Ownership Summary

Jun 2026

As of Jun 2026, promoters hold 63.27% of Narayana Hrudayalaya Ltd (NH) (unchanged from the previous quarter), foreign institutional investors (FII) hold 9.4% and domestic institutional investors (DII) hold 9.06%. Market capitalisation was ₹41,382 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Dec 2015.

Largest disclosed public shareholders in Jun 2026: MIRAE ASSET FLEXI CAP FUND 3.48%, KIRAN MAZUMDAR SHAW 2.3%, RENUKA JAGTIANI 1.24%, PARAG PARIKH FLEXI CAP FUND 1.03%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Jun 202663.27%-9.4%9.06%36.11%
Mar 202663.27%-9.98%9.15%36.11%
Dec 202563.27%-11.1%7.91%36.11%
Sep 202563.85%-10.49%7.76%35.53%
Jun 202563.85%-10.46%8.09%35.53%
Mar 202563.85%-9.66%8.52%35.53%
Dec 202463.85%-9.44%8.69%35.53%
Sep 202463.85%-9.68%7.9%35.53%
Every quarter since Dec 2015 Filing data, not investment advice.